| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/25/2023 | 23.26% | Citigroup | $27 → $31 | Maintains | Buy |
| 08/11/2023 | 7.36% | Citigroup | $23 → $27 | Maintains | Buy |
| 07/27/2023 | -0.6% | Benchmark | → $25 | Reiterates | Buy → Buy |
| 03/02/2023 | -12.52% | Barclays | $13 → $22 | Maintains | Equal-Weight |
| 02/27/2023 | -0.6% | Benchmark | → $25 | Reiterates | → Buy |
| 01/19/2023 | -0.6% | Benchmark | → $25 | Initiates Coverage On | → Buy |
| 10/19/2022 | -36.38% | Citigroup | $20 → $16 | Maintains | Buy |
| 08/02/2022 | -40.36% | Barclays | $18 → $15 | Maintains | Overweight |
| 04/18/2022 | -0.6% | Piper Sandler | $22.5 → $25 | Maintains | Overweight |
| 03/07/2022 | -10.54% | Piper Sandler | $21 → $22.5 | Maintains | Overweight |
| 05/05/2021 | -40.36% | B of A Securities | $12.5 → $15 | Upgrades | Neutral → Buy |
| 08/12/2020 | -76.94% | Piper Sandler | $3.65 → $5.8 | Maintains | Neutral |
| 05/14/2020 | -80.12% | CFRA | $12 → $5 | Maintains | Hold |
| 04/24/2020 | -72.17% | Citigroup | $4 → $7 | Upgrades | Neutral → Buy |
| 04/15/2020 | -84.1% | Piper Sandler | $8.5 → $4 | Maintains | Neutral |
| 04/06/2020 | -84.1% | Bernstein | $9.9 → $4 | Upgrades | Underperform → Market Perform |
| 03/09/2020 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 01/14/2020 | -51.09% | Bernstein | → $12.3 | Initiates Coverage On | → Underperform |
| 12/17/2019 | -20.48% | Goldman Sachs | $16 → $20 | Upgrades | Neutral → Buy |
| 12/12/2019 | -32.41% | Evercore ISI Group | $16 → $17 | Upgrades | In-Line → Outperform |
| 11/21/2019 | -28.43% | Wolfe Research | → $18 | Initiates Coverage On | → Outperform |
| 11/12/2019 | -32.41% | B of A Securities | → $17 | Initiates Coverage On | → Buy |
| 08/15/2019 | -44.33% | Citigroup | $22 → $14 | Maintains | Neutral |
| 03/15/2019 | — | Jefferies | Upgrades | Hold → Buy | |
| 03/11/2019 | -28.43% | Goldman Sachs | → $18 | Initiates Coverage On | → Neutral |
| 02/20/2019 | — | Barclays | Upgrades | Equal-Weight → Overweight | |
| 01/17/2019 | — | JP Morgan | Initiates Coverage On | → Underweight | |
| 12/20/2018 | — | Societe Generale | Downgrades | Buy → Hold | |
| 10/29/2018 | -28.43% | Barclays | $20 → $18 | Maintains | Equal-Weight |
| 10/12/2018 | — | Societe Generale | Upgrades | Hold → Buy |
What is the target price for Oceaneering International (OII)?
The latest price target for Oceaneering International (NYSE: OII) was reported by Citigroup on September 25, 2023. The analyst firm set a price target for $31.00 expecting OII to rise to within 12 months (a possible 23.26% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Oceaneering International (OII)?
The latest analyst rating for Oceaneering International (NYSE: OII) was provided by Citigroup, and Oceaneering International maintained their buy rating.
When is the next analyst rating going to be posted or updated for Oceaneering International (OII)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Oceaneering International, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Oceaneering International was filed on September 25, 2023 so you should expect the next rating to be made available sometime around September 25, 2024.
Is the Analyst Rating Oceaneering International (OII) correct?
While ratings are subjective and will change, the latest Oceaneering International (OII) rating was a maintained with a price target of $27.00 to $31.00. The current price Oceaneering International (OII) is trading at is $25.15, which is out of the analyst's predicted range.